午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook
Chinese English Germany Korean

企業(yè)の連絡(luò)先情報

名前:
電話番號:-
電子メール:sangon@qq.com
國籍:CHINA
ウェブサイト:www.sangon.com
商品の合計數(shù):47239
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318

製品カタログ

5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate, 10 mM in DMS5-[(2R)-2-アミノプロピル]-1-[3-(ベンゾイルオキシ)プロピル]-2,3-ジヒドロ-1H-インドール-7-カルボニトリル(2R,3R)-2,3-ジヒドロキシブタン二酸ビス239463-85-5C26H31N3O8
Taltirelin acetate, 10 mM in DMSO1549593-23-8C19H27N7O7
(3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one, 10 mM in DMSO178408-16-7C14H16N2O2
NVP-TAE 684, 10 mM in DMSO5-クロロ-N-[2-メトキシ-4-[4-(4-メチルピペラジノ)ピペリジノ]フェニル]-N′-[2-(イソプロピルスルホニル)フェニル]-2,4-ピリミジンジアミン761439-42-3C30H40ClN7O3S
LY34051052326428-25-3C26H39N7O3
5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE, 10 mM in DMSO17899-49-9C8H13N3S
AG-270, 10 mM in DMSO2201056-66-6C30H27N5O2
TAK-615, 10 mM in DMSO1664335-55-0C25H22FNO4
TAS0728, 10 mM in DMSO4-アミノ-N-{4-[(ジメチルカルバモイル)メチル]-2,3-ジメチルフェニル}-1-[(3R)-1-(プロパ-2-エノイル)ピペリジン-3-イル]ピラゾロ[3,4-d]ピリミジン-3-カルボキサミド2088323-16-2C26H32N8O3
TAK-020, 10 mM in DMSO1627603-21-7C18H17N5O3
TAK-779, 10 mM in DMSO229005-80-5C33H39N2O2.Cl
TAK-901934541-31-8C28H32N4O3S
Tanimilast1239278-59-1C30H30Cl2F2N2O8S
TAK-593, 10 mM in DMSON-[5-({2-シクロプロパネアミドイミダゾ[1,2-b]ピリダジン-6-イル}オキシ)-2-メチルフェニル]-1,3-ジメチル-1H-ピラゾール-5-カルボキサミド1005780-62-0C23H23N7O3
TAK-243, 10 mM in DMSO1450833-55-2C19H20F3N5O5S2
TAK-6531358751-06-0C19H23N3O3S
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)pyrazine-2-carboxamide, 10 mM in DMSO312508-42-2C14H12N4OS
TAK-659 hydrochloride1952251-28-3C17H22ClFN6O
N,N,O-Tridesmethylvenlafaxine, 10 mM in DMSO149289-29-2C14H21NO2
3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile, 10 mM in DMSO2759137-87-4C18H14N4O
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide,1404117-65-2C27H27Cl2N5O3S
MAT2A inhibitor 4, 10 mM in DMSO1391934-91-0C16H15ClFN
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione26166-92-7C13H9BrN2O4
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione2093536-10-6C20H24N2O6
Fasiglifam, 10 mM in DMSOファシグリファム1000413-72-8C29H32O7S
Taprenepag, 10 mM in DMSOタプレネパグ752187-80-7C24H22N4O5S
NVP-TAE 226, 10 mM in DMSOTAE-226761437-28-9C23H25ClN6O3
TAK-632, 10 mM in DMSON-[2-フルオロ-5-[[2-(シクロプロピルカルボニルアミノ)-7-シアノベンゾチアゾール-6-イル]オキシ]フェニル]-3-(トリフルオロメチル)ベンゼンアセトアミド1228591-30-7C27H18F4N4O3S
Targapremir-210ターガプレミル2101049722-30-6C32H36N10O2
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate, 10 mM in DMSOメタンスルホン酸2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル160969-03-9C11H13F3O5S
TA-02, 10 mM in DMSO1784751-19-4C20H13F2N3
Thalidomide-PEG4-Propargyl2098799-77-8C24H28N2O9
Tanzisertib, 10 mM in DMSOタンジセルチブ899805-25-5C21H23F3N6O2
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide, 10 mM in DMSO2505001-62-5C16H19Cl2N3O4S
Pomalidomide-PEG2-OH2143097-10-1C17H19N3O6
Pomalidomide-PEG3-OH2140807-36-7C19H23N3O7
2-(2,6-dioxopiperidin-3-yl)-4-((9-hydroxynonyl)oxy)isoindoline-1,3-dione2619511-72-5C22H28N2O6
Cyclopenta[c][1]benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aR,4S,9bS)-rel-, 10 mM in DMSO533883-77-1C18H18O3
T-900607, 10 mM in DMSO261944-52-9C14H10F5N3O4S
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine1071135-06-2C23H28N6
Takinib, 10 mM in DMSOタキニブ1111556-37-6C18H18N4O2
Thalidomide-NH-C2-PEG3-OH2140807-23-2C21H27N3O8
NSC 73150, 10 mM in DMSO66680-03-3C12H12N4O2
Subasumstat, 10 mM in DMSO1858276-04-6C25H28ClN5O5S2
Talnetant, 10 mM in DMSOSB-223412174636-32-9C25H22N2O2
GPR34 receptor antagonist 2, 10 mM in DMSO907952-06-1C31H26ClNO4
4-[(E)-{[4,6-Di(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazono}methy l]-2,6-dimethoxyphenol, 10 mM in DMSO321557-16-8C20H27N7O5
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide, 10 mM in DMSO246238-55-1C28H24ClN3O6
TAK-285, 10 mM in DMSON-[2-[4-[[3-クロロ-4-[3-(トリフルオロメチル)フェノキシ]フェニル]アミノ]-5H-ピロロ[3,2-d]ピリミジン-5-イル]エチル]-3-ヒドロキシ-3-メチルブタンアミド871026-44-7C26H25ClF3N5O3
(1S,4R)-N-Desmethyl Sertraline Hydrochloride, 10 mM in DMSO675126-07-5C16H16Cl3N
KCNQ2/3 activator-1, 10 mM in DMSO1009344-33-5C23H29FN2O
TAK-715, 10 mM in DMSON-[4-[2-エチル-4-(3-メチルフェニル)チアゾール-5-イル]-2-ピリジル]ベンズアミド303162-79-0C24H21N3OS
Benzonitrile, 3,3''-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI), 10 mM in DMSO63476-70-0C22H16N2O
TAO Kinase inhibitor 1, 10 mM in DMSO850467-66-2C25H24N2O2
Taprizosin210538-44-6C25H26N6O4S
TAK-071, 10 mM in DMSO4-フルオロ-2-[(3S,4S)-4-ヒドロキシオキサン-3-イル]-5-メチル-6-{[4-(ピラゾール-1-イル)フェニル]メチル}-3H-イソインドール-1-オン1820812-16-5C24H24FN3O3
Takeda-6d, 10 mM in DMSO1125632-93-0C27H19ClFN5O3S
TAM-IN-22135642-56-5C31H27F2N7O3
TAK-441TAK-4411186231-83-3C28H31F3N4O6
Talampanel, 10 mM in DMSOタランパネル161832-65-1C19H19N3O3
SCR130, 10 mM in DMSO2377858-38-1C19H13Cl2N3O2S
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline, 10 mM in DMSO1352608-94-6C22H18BrN7
TAI-1, 10 mM in DMSO1334921-03-7C24H21N3O3S
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-, 10 mM in DMSO80305-11-9C20H25FN2O3
Taminadenant, 10 mM in DMSO5-ブロモ-2,6-ジ(1H-ピラゾール-1-イル)ピリミジン-4-アミン1337962-47-6C10H8BrN7
Fosravuconazole L-lysine ethanolateホスラブコナゾール　L－リシンエタノール付加物914361-45-8C31H40F2N7O8PS
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]-, 10 mM1021917-65-6C19H23N5O3
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, rel-, 10 mM in DMSO1194954-52-3C19H23N9O
GR103545, 10 mM in DMSO126766-43-6C23H29Cl2N3O7
Taladegibタラデギブ1258861-20-9C26H24F4N6O
TAE-11414469-59-2C39H51I3N6O9
Takeda103A, 10 mM in DMSO865609-72-9C24H23F2N7O
C/EBPα inducer 12374285-52-4C20H12FN3O4
TA-01, 10 mM in DMSO1784751-18-3C20H12F3N3
GP130 receptor agonist-1, 10 mM in DMSO339303-87-6C15H11FN2S
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole, 10 mM in DMSO2863687-18-5
Tafetinib1032265-57-8C24H29FN4O2
(D-Trp12,Tyr34)-pTH (7-34) amide (bovine) acetate
1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID, 10 mM in DMSO260555-42-8C13H13NO5
Balipodect, 10 mM in DMSOバリポデクト1238697-26-1C23H17FN6O2
Targocil, 10 mM in DMSOタルゴシル1200443-21-5C21H22ClN5O4S
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-, 10 mM in DMSO939760-13-1C25H22N4O5S
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate, 10 mM in DMSO2738381-94-5C22H18N4O3
Tabernanthalog, 10 mM in DMSO2483829-58-7C14H18N2O
TAK-041, 10 mM in DMSO1929519-13-0C18H15F3N4O3
Tarloxotinib bromide, 10 mM in DMSO1636180-98-7C24H24Br2ClN9O3
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline, 10 mM in DMSO4-[(6,7-ジメトキシキノリン-4-イル)オキシ]アニリン190728-25-7C17H16N2O3
gamma-preprotachykinin amide (72-92) acetate
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, 10 mM in DMSO452105-33-8C16H13FN2O3
Talabostat mesylate, 10 mM in DMSOタラボスタットメシラート150080-09-4C10H23BN2O6S
Exo-1, 10 mM in DMSO461681-88-9C15H12FNO3
TAK-733, 10 mM in DMSO3-[(R)-2,3-ジヒドロキシプロピル]-6-フルオロ-5-[(2-フルオロ-4-ヨードフェニル)アミノ]-8-メチルピリド[2,3-d]ピリミジン-4,7(3H,8H)-ジオン1035555-63-5C17H15F2IN4O4
EAAT2 activator 1, 10 mM in DMSO892415-28-0C16H11ClFN3S
Dazonone, 10 mM in DMSO105622-85-3C11H10ClN3O
TA-03, 10 mM in DMSO5778-80-3C14H16N2O
TAK-960, 10 mM in DMSO4-({9-シクロペンチル-7,7-ジフルオロ-5-メチル-6-オキソ-5H,6H,7H,8H,9H-ピリミド[4,5-b][1,4]ジアゼピン-2-イル}アミノ)-2-フルオロ-5-メトキシ-N-(1-メチルピペリジン-4-イル)ベンズアミド1137868-52-0C27H34F3N7O3
Thalidomide-NH-PEG1-NH2 hydrochloride2154342-56-8C17H21ClN4O5
Acetic acid, 2-[4-[(2-ethyl-3-benzofuranyl)carbonyl]phenoxy]-, 10 mM in DMSO91627-33-7C19H16O5
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid816450-73-4C19H21N3O2
TAK-418, 10 mM in DMSO1818252-53-7
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318
Copyright 2017 ? ChemicalBook. All rights reserved